MedTrace Logo

Rapid HIV Testing and Counseling in Drug Abuse Treatment

NCT00809445 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1281

Last updated 2015-10-14

Study results available
· View outcomes & findings →

Summary

This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV risk behaviors.

Conditions

  • Substance-Related Disorders

Interventions

BEHAVIORAL

On-site HIV rapid test and brief, prevention counseling

Participants will be offered an on-site oral fluid HIV rapid test with brief prevention counseling that addresses both risk reduction and motivation to be HIV tested based on an evidence-based counseling approach.

BEHAVIORAL

On- site HIV rapid test & information

Participants will be offered an on-site oral fluid HIV rapid test with basic info.

BEHAVIORAL

Referral for off-site HIV testing

Participants will be offered a referral list of HIV testing agencies in the community.

Sponsors & Collaborators

Principal Investigators

  • Lisa Metsch, Ph.D. · Columbia University

  • Grant Colfax, M.D. · PATH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-12-31
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00809445 on ClinicalTrials.gov